Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Study Information
Alliance Study ID: NCCTG-969256
NCT Study ID (ClinicalTrials.gov): NCT00003170
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Timothy F. Kozelsky, MD
Status: COMPLETED
Study Description
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Glutamine may be an effective treatment for acute diarrhea caused by radiation therapy. It is not known if glutamine is an effective treatment for acute diarrhea caused by radiation therapy.
PURPOSE: Randomized double-blinded phase III trial to determine the effectiveness of glutamine in preventing acute diarrhea in patients who have pelvic cancer and who are receiving radiation therapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information